Rui Zhao

机构：Torbay Hospital, Torbay and South Devon NHS Foundation Trust · ORCID：0000-0001-5208-1672

发表论文 194 篇 · 总被引 5439 次 · h-index 36

代表论文

• Molecular MRD is strongly prognostic in patients with NPM1-mutated AML receiving venetoclax-based nonintensive therapy (2023 · Blood · 被引 74)
• Real-world outcomes of newly diagnosed AML treated with venetoclax and azacitidine or low-dose cytarabine in the UK NHS (2024 · Blood Neoplasia · 被引 44)
• Regulating the Obesity-Related Tumor Microenvironment to Improve Cancer Immunotherapy (2023 · ACS Nano · 被引 34)
• NOTCH1 mitochondria localization during heart development promotes mitochondrial metabolism and the endothelial-to-mesenchymal transition in mice (2024 · Nature Communications · 被引 28)
• A coordinative dendrimer-based nanovaccine for cancer treatment (2023 · Matter · 被引 27)
• Ibrutinib as first-line therapy for mantle cell lymphoma: a multicenter, real-world UK study (2023 · Blood Advances · 被引 20)